![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 12
Zeitschriftenartikel
Kaesmann, Lukas; Abdo, Reem; Eze, Chukwuka; Dantes, Maurice; Taugner, Julian; Gennen, Kathrin; Roengvoraphoj, Olarn; Rades, Dirk; Belka, Claus und Manapov, Farkhad
(2020):
External Validation of a Survival Score for Limited-Stage Small Cell Lung Cancer Patients Treated with Chemoradiotherapy.
In: Lung, Bd. 198, Nr. 1: S. 201-206
Kaesmann, Lukas; Eze, Chukwuka; Taugner, Julian; Roengvoraphoj, Olarn; Dantes, Maurice; Schmidt-Hegemann, Nina-Sophie; Schiopu, Sanziana; Belka, Claus und Manapov, Farkhad
(2020):
Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy.
In: Radiation Oncology, Bd. 15, Nr. 1, 167
Taugner, Julian; Kaesmann, Lukas; Eze, Chukwuka; Dantes, Maurice; Roengvoraphoj, Olarn; Gennen, Kathrin; Karin, Monika; Petruknov, Oleg; Tufman, Amanda; Belka, Claus und Manapov, Farkhad
(2019):
Survival score to characterize prognosis in inoperable stage III NSCLC after chemoradiotherapy.
In: Translational Lung Cancer Research, Bd. 8, Nr. 5: S. 593-604
Kaesmann, Lukas; Taugner, Julian; Eze, Chukwuka; Roengvoraphoj, Olarn; Dantes, Maurice; Gennen, Kathrin; Karin, Monika; Petrukhnov, Oleg; Tufman, Amanda; Belka, Claus und Manapov, Farkhad
(2019):
Performance Status and Its Changes Predict Outcome for Patients With Inoperable Stage III NSCLC Undergoing Multimodal Treatment.
In: Anticancer Research, Bd. 39, Nr. 9: S. 5077-5081
Kaesmann, Lukas; Eze, Chukwuka; Dantes, Maurice; Roengvoraphoj, Olarn; Niyazi, Maximilian; Belka, Claus und Manapov, Farkhad
(2019):
State of clinical research of radiotherapy/chemoradiotherapy and immune checkpoint inhibitor therapy combinations in solid tumours-a German radiation oncology survey.
In: European Journal of Cancer, Bd. 108: S. 50-54
Roengvoraphoj, Olarn; Wijaya, Cherylina; Eze, Chukwuka; Li, Minglun; Dantes, Maurice; Taugner, Julian; Tufman, Amanda; Huber, Rudolf Maria; Belka, Claus und Manapov, Farkhad
(2018):
Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer.
In: Strahlentherapie und Onkologie, Bd. 194, Nr. 2: S. 107-115
Roengvoraphoj, Olarn; Eze, Chukwuka; Wijaya, Cherylina; Dantes, Maurice; Taugner, Julian; Tufman, Amanda; Huber, Rudolf Maria; Bartenstein, Peter; Belka, Claus und Manapov, Farkhad
(2018):
How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experience.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 45, Nr. 12: S. 2103-2109
Manapov, Farkhad; Roengvoraphoj, Olarn; Dantes, Maurice; Marschner, Sebastian; Li, Minglun und Eze, Chukwuka
(2018):
Pneumonitis in Irradiated Lungs After Nivolumab: A Brief Communication and Review of the Literature.
In: Journal of Immunotherapy, Bd. 41, Nr. 2: S. 96-99
[PDF, 174kB]
Manapov, Farkhad; Käsmann, Lukas; Roengvoraphoj, Olarn; Dantes, Maurice; Schmidt-Hegemann, Nina-Sophie; Belka, Claus und Eze, Chukwuka
(2018):
Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes.
In: Lung Cancer-Targets and Therapy, Bd. 9: S. 49-55
[PDF, 163kB]
Eze, Chukwuka; Roengvoraphoj, Olarn; Dantes, Maurice; Abdo, Reem; Kaesmann, Lukas; Schmidt-Hegemann, Nina-Sophie; Belka, Claus und Manapov, Farkhad
(2018):
Prophylactic Cranial Irradiation for Patients with Small Cell Lung Cancer in Germany: Pattern of Care Survey.
In: Anticancer Research, Bd. 38, Nr. 9: S. 5261-5265
Eze, Chukwuka; Roengvoraphoj, Olarn; Dantes, Maurice und Manapov, Farkhad
(2017):
Is it time to convert the frequency of radiotherapy in small-cell lung cancer?
In: Lancet Oncology, Bd. 18, Nr. 10, E555-E555
Eze, Chukwuka; Hegemann, Nina-Sophie; Roengvoraphoj, Olarn; Dantes, Maurice und Manapov, Farkhad
(2017):
Concurrent Afatinib and Whole-Brain Radiotherapy in Exon 19-del-EGFR Mutant Lung Adenocarcinoma: A Case Report and Mini Review of the Literature.
In: Frontiers in Oncology, Bd. 7, 88
[PDF, 947kB]